跳至主要内容
临床试验/CTIS2022-501312-34-00
CTIS2022-501312-34-00进行中(未招募)1 期

The Intertransverse Process Block for Minor Breast Cancer Surgery – Single or Multiple Injection?A randomised, procedure related, blinded clinical trial. - ZUH-ITP-MBCS

Zealand University Hospital0 个研究点目标入组 30 人开始时间: 2022年7月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)

入选标准

  • Patients scheduled for day case elective unilateral minor breast cancer (including DCIS) surgery, Age = 18 years at the date of inclusion, American Associations of Anaesthesiologist (ASA) class I-III, Have received thorough information, orally and in written form, and signed the Informed Consent” form on participation in the study., Weight > 52,5 kilograms (chosen due to the maximum single dose of Ropivacaine (3mg/kg))

排除标准

  • Substantial co-morbidity: American Associations of Anaesthesiologist (ASA) class > III, Any systemic muscular or neuromuscular disease, Any use of vasodilatory substance (investigators decision), Local infection at the site of injection or systemic infection, Difficult sonoanatomical visualisation of the target area (SCTL, ITTC etc.) necessary for the block execution, Severe hypovolemia, Pregnant or breastfeeding, Inability to speak and understand Danish, Inability to cooperate, Allergy to study drugs, Daily intake of analgesics (investigators decision), Alcohol and/or drug overuse (investigators decision), Previous thoracic trauma or thoracic surgery, Previous/current piercing of the nipple of any kind on blockade side, Tattoos on the thorax (according to the investigators decision)

研究者

相似试验

ITP BLOCK FOR MINOR BREAST CANCER SURGERY | 临床试验